Product dossierBuilt from registrations, label text and platform-curated data

艾佰瑞交联胶原蛋白植入剂

艾佰瑞 is a Collagen product (Class III device), registered by 北京艾佰瑞生物技术有限公司. Linked registrations: China 国械注准20263131506. First approved in China on 2026-07-20 (国械注准20263131506). Data as of 2026-10-24.

  • Regulatory classCollagen · Class III device
  • Holder北京艾佰瑞生物技术有限公司
  • JurisdictionsCN
  • Updated2026-10-24 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

艾佰瑞

Product
Regulatory class
Class III device
Category
Collagen
China · NMPA device registration
国械注准20263131506
Name on registration
交联胶原蛋白植入剂
Registrant
北京艾佰瑞生物技术有限公司
First approval
2026-07-20
This certificate issued
2026-07-20
Valid until
2031-07-19
Models and sizes
PCCG-010:1mL/支,PCCG-005:0.5mL/支。
Checked against official page
2026-10-23

Public: fields from the registration record.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. CN

    国械注准20263131506 first approved

  2. CN

    国械注准20263131506 change

    首次获批(受理号 CQZ2501473;2026年07月21日医疗器械批准证明文件送达信息)

  3. CN

    国械注准20263131506 change

    延续或变更注册获批(受理号 CQD2602331;2026年08月04日医疗器械批准证明文件送达信息)

  4. CN

    国械注准20263131506 change

    官网变更:载明生产地址由:北京市昌平区科技园区双营西路79号院33号楼2层、B1层;载明生产地址变更为:北京市昌平区双营西路79号院33号楼2层、B1层

  5. CN

    国械注准20263131506 valid until

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

3
  • 国械注准20263131506: 延续或变更注册获批(受理号 CQD2602331;2026年08月04日医疗器械批准证明文件送达信息)2026-07-28
  • 国械注准20263131506: 官网变更:载明生产地址由:北京市昌平区科技园区双营西路79号院33号楼2层、B1层;载明生产地址变更为:北京市昌平区双营西路79号院33号楼2层、B1层2026-07-28
  • 国械注准20263131506: 首次获批(受理号 CQZ2501473;2026年07月21日医疗器械批准证明文件送达信息)2026-07-20

Sources

1